Prognostic impact of high p16/cyclin D1 index in breast cancer

被引：1

作者：

Kim, Gi Jeong ^{[1
,2
]}

Kim, Dong-Hoon ^{[3
]}

Min, Kyueng-Whan ^{[4
]}

Kim, Se Hoon ^{[5
]}

机构：

[1] Gachon Univ, Gil Med Ctr, Dept Pathol, Coll Med, Incheon, South Korea

[2] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea

[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, 29 Saemunanro, Seoul 03181, South Korea

[4] Hanyang Univ, Guri Hosp, Dept Pathol, Coll Med, Guri, Gyeonggi Do, South Korea

[5] Yonsei Univ, Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea

来源：

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2019年 / 12卷 / 06期

关键词：

Breast cancer; p16; cyclin D1; index; prognosis; CYCLIN D1; RETINOBLASTOMA PROTEIN; P16; PROTEINS; EXPRESSION; OVEREXPRESSION; CARCINOMA; METHYLATION; RB; PROGRESSION; P16(INK4A);

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Proteins p16 and cyclin D1 (CCND1) are known to tightly regulate the G1/S transition during the cell cycle, but their role in breast cancer development and progression is not clear. We investigated 224 cases of breast cancer from the Kangbuk Samsung Medical Center between 2000-2005. Expression levels of p16 and CCND1 were assessed by tissue microarray-based immunohistochemistry. A p16/CCND1 index was divided into low- and high-expression groups using receiver operating characteristic curves. The p16/CCND1 index was significantly different across molecular subtypes and a high p16/CCND1 index was statistically correlated with survival rates. This p16/CCND1 index may be an indicator of poor patient outcome and thus, represents a potential therapeutic target.

引用

页码：2224 / 2232

页数：9

共 50 条

[41] EXPRESSION OF p16,CYCLIN D1 AND RB PROTEIN IN GASTRIC CARCINOMA AND PREMALIGNANT LESIONS
缪林
赵志泉
季国忠
范志宁
金宁
刘政
张平
程铁华
ChineseJournalofCancerResearch, 2003, (01) : 61 - 65
[42] Identification of CDK4 sequences involved in cyclin D1 and p16 binding
Coleman, KG
Wautlet, BS
Morrissey, D
Mulheron, J
Sedman, SA
Brinkley, P
Price, S
Webster, KR
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18869 - 18874
[43] Telomerase activity and abnormal expression of p16 and cyclin D1 in Barrett's esophagus
Ozawa, S
Ueda, M
Koyanagi, K
Takeuchi, H
Ando, N
Kitajima, M
GASTROENTEROLOGY, 1997, 112 (04) : A635 - A635
[44] The effect of the sun on expression of β-catenin, p16 and cyclin d1 proteins in melanocytic lesions
Demirkan, N. C.
Kesen, Z.
Akdag, B.
Larue, L.
Delmas, V.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (06) : 733 - 739
[45] Alterations in the RB, p16, and cyclin D1 cell cycle control pathway in osteosarcomas
Belchis, DA
Gocke, CD
Geradts, J
PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2000, 19 (05): : 377 - 389
[46] Increased protein expression of p16 and cyclin D1 in squamous cell carcinoma tissues
Eshkoor, Sima Ataollahi
Ismail, Patimah
Rahman, Sabariah Abdul
Mirinargesi, Mirsaed
Oshkour, Soraya Ataollahi
BIOSCIENCE TRENDS, 2009, 3 (03) : 105 - 109
[47] OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16
Fandou Kong
Rui Tong
Lingyu Jia
Wei Wei
Xiaoyan Miao
Xinyu Zhao
Wenping Sun
Guang Yang
Chunyan Zhao
Molecular and Cellular Biochemistry, 2011, 354 : 199 - 205
[48] OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16
Kong, Fandou
Tong, Rui
Jia, Lingyu
Wei, Wei
Miao, Xiaoyan
Zhao, Xinyu
Sun, Wenping
Yang, Guang
Zhao, Chunyan
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 354 (1-2) : 199 - 205
[49] Prognostic Impact of Cyclin D1, Cyclin E and P53 on Gastroenteropancreatic Neuroendocrine Tumours
Liu, Shu-Zheng
Zhang, Fang
Chang, Yu-xi
Ma, Jie
Li, Xu
Li, Xiao-Hong
Fan, Jin-Hu
Duan, Guang-Cai
Sun, Xi-Bin
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (01) : 419 - 422
[50] Expression of pRb, p53, p16 and Cyclin D1 and Their Clinical Implications in Urothelial Carcinoma
Lee, Kyungji
Jung, Eun Sun
Choi, Young-Jin
Lee, Kyo Young
Lee, Ahwon
JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (10) : 1449 - 1455

← 1 2 3 4 5 →